Epigenetic age testing: how it differs from a DNA test

A DNA test and an epigenetic age test both start with your cells and end somewhere completely different — one reads a document fixed at conception, the other reads how hard life has been annotating it.

Two different layers of the same molecule

A DNA test reads sequence — the order of letters you inherited. It is the same in essentially every cell, unchanged across your lifetime: measure it at 8 or 80 and the answer matches. That permanence is its nature and its limit — sequence describes what you were dealt, nothing about how the hand is going.

An epigenetic test reads methylation — small chemical marks attached to the DNA that help govern which genes are active. These marks change: with age above all, and to a lesser degree with smoking, metabolic health and other exposures. They are annotation on the text, not the text — and because they change, they can carry information about state, which fixed sequence never could.

How the marks become an age

Methylation at certain positions shifts with age so consistently that algorithms — epigenetic clocks — can estimate age from a sample with striking population-level accuracy. Research versions go further, training on health outcomes rather than birthdays, aiming to estimate something like pace of ageing. At the research scale, faster-than-calendar readings associate with worse outcomes; that association is the genuine science underneath the consumer products.

The gap between lab and product

The consumer caveats mirror biological age testing generally, with one technical addition. Different providers use different clocks, so numbers are not comparable between them. The measurement itself is noisy — the same sample run twice can return estimates years apart, which dwarfs the "you aged 1.5 years younger!" precision the marketing implies. And no clinical decision anywhere runs on an epigenetic age. The defensible use is the same as its blood-marker cousin: a long-run trend with a single provider, read loosely — while the behaviours that move it are the same unglamorous ones that need no test to justify.

What an epigenetic age won't tell you

• Your inherited risks. That is sequence's territory — this test reads the annotation, not the letters.
• A precise personal verdict. Technical noise and provider variation soften every individual number.
• What specifically to change. The clock summarises; it cannot itemise causes.
• Anything a doctor acts on. Clinical assessment of ageing runs through measured health, not methylation — for now, and honestly perhaps for a while.

The bottom line

DNA testing reads the hand you were dealt; epigenetic testing estimates how the game is going — genuinely different questions from the same molecule. The first is fixed fact, the second a promising, noisy estimate: interesting as a trend, oversold as a verdict, and no substitute for the markers that already measure the game directly.